Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights India And Oman Pharmaceutical Industry Market

Published Date : Aug 2021

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition, and patent cliffs. Innovation is of v... View more

Coherent Market Insights Allergic Conjunctivitis Market

Published Date : Aug 2021

More than 20% of the global population is affected by eye condition called Allergic conjunctivitis. It is an allergic reaction of the outer lining of the eyeball (conjunctiva) to particles in the environment that act as allergens to certain individuals. Dust, pollen, ... View more

Coherent Market Insights Us Severe Oral Mucositis Market

Published Date : Aug 2021

Oral mucositis refers to tissue swelling in the mouth. Radiation therapy or chemotherapy may cause mucositis. Oral mucositis is an erythematous and ulcerative lesion of the oral mucosa observed in patients with cancer who are treated with chemotherapy, and/or with rad... View more

Coherent Market Insights Fungal Otitis Externa Market

Published Date : Jul 2021

Fungal otitis externa is an infection of the outer ear canal. Fungal otitis externa mostly affects people who live in warm or tropical areas. It also often affects people who swim frequently, live with diabetes, or have other chronic medical and skin conditions. The S... View more

Coherent Market Insights Immunodeficiency Therapeutics Market

Published Date : Jul 2021

Immunodeficiency disorders or diseases render the ability of the immune system to fight against microbial infection, thus making a person immuno-compromised. Thus, people suffering from immunodeficiency diseases or disorders are more likely to fall sick. An immunodefi... View more

Coherent Market Insights Polycythemia Vera Therapeutics Market

Published Date : Jul 2021

Polycythemia vera is a blood disorder in which the body creates too many red blood cells. These extra red cells make blood thicker than normal. The thickened blood flows slower and may clot within body. Red blood cells carry oxygen to organs and tissues throughout the... View more

Coherent Market Insights Genital Warts Treatment Market

Published Date : Jul 2021

Genital warts are a common sexually transmitted infection (STI) that is passed on by vaginal and anal intercourse, sharing sex toys, and rarely, by oral sex. There are various treatments that are available for the t... View more

Coherent Market Insights Castrate Resistant Prostate Cancer Market

Published Date : Jul 2021

Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer that is resistant to testosterone-lowering treatments. Symptoms of mCRPC include: difficulty urinating, pain while passing urine, or blood in the urine, weight loss and shortness of breath. Hormonal therapies are us... View more

Coherent Market Insights Biodefense Market

Published Date : Jul 2021

Biodefense is a military or emergency response term that is frequently discussed in the context of bio-war or bioterrorism. Biodefense also refers to actions taken to restore biosecurity to a group of organisms that are or may be vulnerable to biological threats or in... View more

Coherent Market Insights Us Europe And China Myelodysplastic Syndrome Treatment Market

Published Date : Jul 2021

In myelodysplastic syndrome (MDS), some of the blood forming cells in bone marrow become abnormal and have problems in forming new and mature blood cells. The immature blood cells called as blasts get stored in the bone marrow and blood, and obstruct the natural funct... View more

Coherent Market Insights Us Liposomal Doxorubicin Market

Published Date : Jul 2021

Liposomal doxorubicin is a chemotherapy drug, which is administered intravenously to treat AIDS-related Kaposi's sarcoma, breast cancer, ovarian cancer, and other solid tumors. Doxorubicin acts by blocking an enzyme called topoisomerase 2 that cancer cells need in ord... View more

Coherent Market Insights Prurigo Nodularis Therapeutics Market

Published Date : Jul 2021

Prurigo Nodularis is skin disease that causes hard and itchy lumps on skin, which usually appears on the arms or legs. Prurigo nodularis is a rare disease and currently, the treatment of the disease is still in research and development process. Treatments may include ... View more

Coherent Market Insights Female Infertility Treatment Drugs Market

Published Date : Jun 2021

Female infertility refers to a condition where a woman is unable to conceive after at least one year of having unprotected sex. Various factors such as age, hormone imbalance, physical health, and lifestyle can lead to female infertility. Ovulation testing, Hysterosal... View more

Coherent Market Insights Vitiligo Drugs Market

Published Date : Jun 2021

Vitiligo is a disease that causes loss of skin colour in patches. The discoloured areas usually get bigger with time. The condition usually affects the skin on any part of the body. It can also affect hair and the inside of the mouth. The colour of hair and skin is de... View more

Coherent Market Insights India Mucormycosis Treatment Market

Published Date : May 2021

Mucormycosis is a rapidly progressive and life-threatening invasive fungal disease with high morbidity and mortality rates despite treatment. It primarily affects immunocompromised patients such as those with organ and bone marrow transplantation, hematological malign... View more

Coherent Market Insights Urea Cycle Disorder Treatment Market

Published Date : May 2021

The global urea cycle disorders treatment market includes various therapies such as amino acid supplements, sodium phenylbutyrate, glycerol phenylbutyrate, sodium benzoate, low protein diet, carglumic acid, etc. for the treatment of the inherited disorder such as urea... View more

Coherent Market Insights Latin America Pharmaceutical Products Cmo Market

Published Date : Feb 2021

Pharmaceutical products CMO provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Contract manufacturing organizations offer services from development of... View more

Coherent Market Insights Methadone Hydrochloride Market

Published Date : Dec 2020

Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance thera... View more

Coherent Market Insights Pediatric Electrolyte Solution Market

Published Date : Dec 2020

Pediatric electrolyte solution is used to replace fluids and minerals such as sodium and potassium, which are lost due to diarrhea and vomiting. This solution helps to prevent or treat dehydration i.e. the excessive loss of body water. The right amount of fluids and m... View more

Coherent Market Insights Glucosamine Market

Published Date : Dec 2020

The global glucosamine market include various different product types such as powder, tablets, capsules and liquids. Glucosamine is naturally synthesized in the human body, used as a health supplement and can be used in the treatment of various conditions such as rheu... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.